Vaccination Started in India | Impact over Indian Economy & World?

[South Park]

India is facing definitely a big obstabcle with their huge population compared to other countries. Also the size of the country makes vaccination centers a huge logistical problem. One good thing is that AstraZeneca is offering the cheapest corona vaccine at the moment for India. With a dose for the vaccine between $1-2 its much more affordable in large quantities compared to the Morderna or Pfizer vaccine.

That is really cheap, the other vaccines are many times more costly so this could be the only option for the government of India to vaccinate most of its population, however we must not only look at the cost India is such a huge country that reaching everyone is going to be difficult so we need to know at which temperatures the vaccine needs to be maintained so it does not lose its effectiveness along the way, after all if it needs the same temperatures as the vaccine of Pfizer then even at the low cost it may not be worth it.

[1714634636]

1714634636

[1714634636]

1714634636

[1714634636]

1714634636

[Sithara007]

That is really cheap, the other vaccines are many times more costly so this could be the only option for the government of India to vaccinate most of its population, however we must not only look at the cost India is such a huge country that reaching everyone is going to be difficult so we need to know at which temperatures the vaccine needs to be maintained so it does not lose its effectiveness along the way, after all if it needs the same temperatures as the vaccine of Pfizer then even at the low cost it may not be worth it.

From what I have heard, the vaccines from Pfizer needs to be stored in ultra-deep freezers, where temperatures of -70 degrees need to be maintained. But that is not the case with the two vaccines that are being used in India (Covishield from Oxford/AstraZeneca and Covaxin from Bharat Biotech). These two vaccines can be stored with regular refrigeration. The question is regarding the efficacy, and not about the cost or the logistic issues. The phase III trials for Covishied showed an efficacy of only 62%, which is far below the 95% level reported for Pfizer and Moderna. And the second vaccine (Covaxin) is yet to complete it's phase III trials.

[Webetcoins]

What do you guys think about India and it’s economy ? Whether they will have advantage over other nations in grabbing more economic throughput due to vaccination??

I have already started seeing it in the news that their economy will be among the fast rising economies this year, although it was just the headline that I read, I didn’t bother much in checking what reasons because I didn’t read the news. But, if they have really started the vaccination, I believe it’s going to help them, once people gets back to work in every sectors it’s going to help in boosting their economies to a high level, and as have been predicted by so many media sites, they will be among the fastest growing economies this year.

[South Park]

That is really cheap, the other vaccines are many times more costly so this could be the only option for the government of India to vaccinate most of its population, however we must not only look at the cost India is such a huge country that reaching everyone is going to be difficult so we need to know at which temperatures the vaccine needs to be maintained so it does not lose its effectiveness along the way, after all if it needs the same temperatures as the vaccine of Pfizer then even at the low cost it may not be worth it.

From what I have heard, the vaccines from Pfizer needs to be stored in ultra-deep freezers, where temperatures of -70 degrees need to be maintained. But that is not the case with the two vaccines that are being used in India (Covishield from Oxford/AstraZeneca and Covaxin from Bharat Biotech). These two vaccines can be stored with regular refrigeration. The question is regarding the efficacy, and not about the cost or the logistic issues. The phase III trials for Covishied showed an efficacy of only 62%, which is far below the 95% level reported for Pfizer and Moderna. And the second vaccine (Covaxin) is yet to complete it's phase III trials.

Even if that efficiency is kind of low it is still good enough as it is better to have some protection than to have no protection at all, also I do not know but even if the efficiency is kind of low could this be increased by more vaccine being applied? Because as we know this world moves with money and the Pfizer vaccine costs 20 dollars, which is not much but when you have to vaccinate hundreds of millions of people that can quickly add up.